Outcomes of fenestrated and branched endovascular aortic repair for chronic post-dissection thoracoabdominal aortic aneurysms

Marino, Pablo Marqués de; Ibraheem, Anas; Gafur, Nargis; Verhoeven, Eric L.G.; Katsargyris, Αthanasios

doi:10.23736/s0021-9509.20.11367-3

Cited by 7 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, fenestrated and branched EVAR (F/BEVAR), which emerged as new techniques to treat more complicated cases with an endovascular approach, are being used with increasing frequency for the treatment of post-dissection thoracoabdominal aneurysms (PDTAAAs) [22][23][24]. However, early experiences with F/BEVAR for PDTAAAs have underlined specific difficulties due to a noncompliant dissection septum and compromised true lumen, variable (from different lumens) origins of the visceral vessels and the common use of diseased aortic landing zones [24].…”

Section: Introductionmentioning

confidence: 99%

A Systematic Review and an Updated Meta-Analysis of Fenestrated/Branched Endovascular Aortic Repair of Chronic Post-Dissection Thoracoabdominal Aortic Aneurysms

Mylonas,

Aras,

Dorweiler

2024

JCM

View full text Add to dashboard Cite

The objective of this study is to present the current outcomes of fenestrated/branched endovascular repair (F/BEVAR) for post-dissection thoracoabdominal aortic aneurysms (PDTAAAs). A systematic review of the literature according to PRISMA guidelines up to October 2023 was conducted (protocol CRD42023473403). Studies were included if ≥10 patients were reported and at least one of the major outcomes was stated. A total of 10 studies with 585 patients overall were included. The pooled estimate for technical success was 94.3% (95% CI 91.4% to 96.2%). Permanent paraplegia developed with a pooled rate of 2.5% (95% CI 1.5% to 4.3%), whereas a cerebrovascular event developed with a pooled rate of 1.6% (95% CI 0.8% to 3.0%). An acute renal function impairment requiring new-onset dialysis occurred with a pooled rate of 2.0% (95% CI 1.0% to 3.8%). Postoperative respiratory failure was observed with a pooled estimate of 5.5% (95% CI 3.8% to 8.1%). The pooled estimate for 12-month overall survival was 90% (95% CI 85% to 93.5%), and the pooled estimates for 24-month and 36-month survival were 87.8% (95% CI 80.9% to 92.5%) and 85.5% (95% CI 76.5% to 91.5%), respectively. Freedom from reintervention was estimated at 83.9% (95% CI 75.9% to 89.6%) for 12 months, 82.8% (95% CI 68.7% to 91.4%) for 24 months and 76.1% (95% CI 60.6% to 86.8%) for 36 months. According to the present findings, F/BEVAR can be performed in PD-TAAAs with high rates of technical success and good mid-term results.

show abstract

Section: Introductionmentioning

confidence: 99%